Pleural infection: Past, present, and future directions

The Lancet Respiratory Medicine

Volumn 3, Issue 7, 2015, Pages 563-577

  Corcoran, John P ^a,b   Wrightson, John M ^a,b,c   Belcher, Elizabeth ^a   DeCamp, Malcolm M ^d   Feller Kopman, David ^e   Rahman, Najib M ^a,b,c  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NORTHWESTERN UNIVERSITY   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEOXYRIBONUCLEASE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN; PLACEBO; PNEUMOCOCCUS VACCINE; STREPTODORNASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VASCULOTROPIN; ANTIINFECTIVE AGENT; FIBRINOLYTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL TRANSLOCATION; COMMENSAL; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC VALUE; FIBRINOLYTIC THERAPY; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LUNG LOBECTOMY; LUNG RESECTION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PERCUTANEOUS DRAINAGE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURISY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS MILLERI; STREPTOCOCCUS PNEUMONIAE; THORACOTOMY; THORAX DRAINAGE; VIDEO ASSISTED THORACOSCOPIC SURGERY; VIRUS PNEUMONIA; ADULT; ANIMAL; BACTERIAL INFECTIONS; DISEASE MODEL; FORECASTING; MYCOSES; PLEURAL DISEASES; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; TRENDS;

ADULT; ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; FORECASTING; HUMANS; MYCOSES; PLEURAL DISEASES; PROGNOSIS; RESPIRATORY TRACT INFECTIONS; STREPTOKINASE; THORACIC SURGERY, VIDEO-ASSISTED; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84943147080     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00185-X     Document Type: Review

References (131)

1. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR Emergence of parapneumonic empyema in the USA. Thorax 2011, 66:663-668.
2. Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007, 133:346-351.
3. Li ST, Tancredi DJ Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010, 125:26-33.
4. Roxburgh CS, Youngson GG, Townend JA, Turner SW Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 2008, 93:316-318.
5. Davies HE, Davies RJ, Davies CW Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010, 65(suppl 2):ii41-ii53. the BTS Pleural Disease Guideline Group.
6. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008, 46:174-182.
7. Koshy E, Murray J, Bottle A, Sharland M, Saxena S Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax 2010, 65:770-774.
8. Maskell NA, Davies CW, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005, 352:865-874. the First Multicenter Intrapleural Sepsis Trial (MIST1) Group.
9. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011, 365:518-526.
10. Nielsen J, Meyer CN, Rosenlund S Outcome and clinical characteristics in pleural empyema: a retrospective study. Scand J Infect Dis 2011, 43:430-435.
11. Desai G, Amadi W Three years' experience of empyema thoracis in association with HIV infection. Trop Doct 2001, 31:106-107.
12. Marks DJ, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre. PLoS One 2012, 7:e30074.
13. Davies HE, Rosenstengel A, Lee YC The diminishing role of surgery in pleural disease. Curr Opin Pulm Med 2011, 17:247-254.
14. Corcoran JP, Rahman NM Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes. Chest 2014, 145:14-17.
15. Suchar AM, Zureikat AH, Glynn L, Statter MB, Lee J, Liu DC Ready for the frontline: is early thoracoscopic decortication the new standard of care for advanced pneumonia with empyema?. Am Surg 2006, 72:688-692.
16. Scarci M, Zahid I, Billé A, Routledge T Is video-assisted thoracoscopic surgery the best treatment for paediatric pleural empyema?. Interact Cardiovasc Thorac Surg 2011, 13:70-76.
17. Lee SF, Lawrence D, Booth H, Morris-Jones S, Macrae B, Zumla A Thoracic empyema: current opinions in medical and surgical management. Curr Opin Pulm Med 2010, 16:194-200.
18. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest 2000, 118:1158-1171.
19. Strange C, Sahn SA The definitions and epidemiology of pleural space infection. Semin Respir Infect 1999, 14:3-8.
20. Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009, 64:592-597.
21. Nasreen N, Mohammed KA, Hardwick J, et al. Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: role of intercellular adhesion molecule-1. J Infect Dis 2001, 183:1638-1645.
22. Kroegel C, Antony VB Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997, 10:2411-2418.
23. Zhu Z, Hawthorne ML, Guo Y, et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006, 129:1577-1583.
24. Xiol X, Castellví JM, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology 1996, 23:719-723.
25. Jaffe A, Calder AD, Owens CM, Stanojevic S, Sonnappa S Role of routine computed tomography in paediatric pleural empyema. Thorax 2008, 63:897-902.
26. Tu CY, Chen CH Spontaneous bacterial empyema. Curr Opin Pulm Med 2012, 18:355-358.
27. Wilkosz S, Edwards LA, Bielsa S, et al. Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae. Am J Respir Cell Mol Biol 2012, 46:180-187.
28. Light RW, MacGregor MI, Ball WC, Luchsinger PC Diagnostic significance of pleural fluid pH and PCO2. Chest 1973, 64:591-596.
29. Sahn SA, Reller LB, Taryle DA, Antony VB, Good JT The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis 1983, 128:811-815.
30. Heffner JE, Brown LK, Barbieri C, DeLeo JM Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med 1995, 151:1700-1708.
31. Idell S, Girard W, Koenig KB, McLarty J, Fair DS Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991, 144:187-194.
32. Mutsaers SE, Kalomenidis I, Wilson NA, Lee YC Growth factors in pleural fibrosis. Curr Opin Pulm Med 2006, 12:251-258.
33. Kunz CR, Jadus MR, Kukes GD, Kramer F, Nguyen VN, Sasse SA Intrapleural injection of transforming growth factor-beta antibody inhibits pleural fibrosis in empyema. Chest 2004, 126:1636-1644.
34. El Solh AA, Alhajjhasan A, Ramadan FH, Pineda LA A comparative study of community- and nursing home-acquired empyema thoracis. J Am Geriatr Soc 2007, 55:1847-1852.
35. Diacon AH, Brutsche MH, Solèr M Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound. Chest 2003, 123:436-441.
36. Mercaldi CJ, Lanes SF Ultrasound guidance decreases complications and improves the cost of care among patients undergoing thoracentesis and paracentesis. Chest 2013, 143:532-538.
37. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006, 174:817-823.
38. Rahman NM, Mishra EK, Davies HE, Davies RJ, Lee YC Clinically important factors influencing the diagnostic measurement of pleural fluid pH and glucose. Am J Respir Crit Care Med 2008, 178:483-490.
39. Davies CW, Kearney SE, Gleeson FV, Davies RJ Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999, 160:1682-1687.
40. Huang HC, Chang HY, Chen CW, Lee CH, Hsiue TR Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest 1999, 115:751-756.
41. Chen CH, Chen W, Chen HJ, et al. Transthoracic ultrasonography in predicting the outcome of small-bore catheter drainage in empyemas or complicated parapneumonic effusions. Ultrasound Med Biol 2009, 35:1468-1474.
42. Havelock T, Teoh R, Laws D, Gleeson F Pleural procedures and thoracic ultrasound: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010, 65(suppl 2):ii61-ii76. the BTS Pleural Disease Guideline Group.
43. Rahman NM, Singanayagam A, Davies HE, et al. Diagnostic accuracy, safety and utilisation of respiratory physician-delivered thoracic ultrasound. Thorax 2010, 65:449-453.
44. Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest 2014, 145:848-855.
45. Sasse SA, Causing LA, Mulligan ME, Light RW Serial pleural fluid analysis in a new experimental model of empyema. Chest 1996, 109:1043-1048.
46. Strange C, Allen ML, Harley R, Lazarchick J, Sahn SA Intrapleural streptokinase in experimental empyema. Am Rev Respir Dis 1993, 147:962-966.
47. Fletcher MA, Schmitt HJ, Syrochkina M, Sylvester G Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis 2014, 33:879-910.
48. Varano Della Vergiliana JF, Lansley SM, Porcel JM, et al. Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. PLoS One 2013, 8:e63873.
49. Lee Y, Varnao J, Rashwan R, Waterer G, Townsend T, Kay I Staphylococcus aureus, but not other bacterial empyema pathogens, induce the release of selected cytokines from mesothelial cells. Respirology 2014, 19(suppl 2):128.
50. Brims F, Rosenstengal A, Yogendran, et al. The bacteriology of pleural infection in Western Australia. Am J Respir Crit Care Med 2014, 189:A5472.
51. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011, 30:289-294.
52. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004, 59:522-525.
53. Meyer CN, Rosenlund S, Nielsen J, Friis-Møller A Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis 2011, 43:165-169.
54. Chen KY, Hsueh PR, Liaw YS, Yang PC, Luh KT A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000, 117:1685-1689.
55. Lin YT, Chen TL, Siu LK, Hsu SF, Fung CP Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:1003-1010.
56. Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008, 27:1030-1032.
57. Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 2011, 53:254-261.
58. Grau I, Ardanuy C, Calatayud L, et al. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One 2012, 7:e42595.
59. Thomas MF, Sheppard CL, Guiver M, et al. Emergence of pneumococcal 19A empyema in UK children. Arch Dis Child 2012, 97:1070-1072.
60. Lai CY, Huang LM, Lee PY, Lu CY, Shao PL, Chang LY Comparison of invasive pneumococcal disease caused by serotype 19A and non-19A pneumococci in children: more empyema in serotype 19A invasive pneumococcal disease. J Microbiol Immunol Infect 2014, 47:23-27.
61. Byington CL, Hulten KG, Ampofo K, et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010, 48:520-525.
62. Thomas MF, Sheppard C, Guiver M, et al. Paediatric pneumococcal empyema serotypes have not changed following introduction of the 13 valent pneumococcal vaccine. Thorax 2013, 68:A39.
63. Smith DT Experimental aspiratory abscess. Arch Surg 1927, 14:231-239.
64. Wrightson JM, Wray JA, Street TL, Chapman SJ, Crook DW, Rahman NM S114: Previously unrecognised oral anaerobes in pleural infection. Thorax 2014, 69(suppl S2):A61-A62.
65. Shinzato T, Saito A A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe. J Med Microbiol 1994, 40:118-123.
66. Boyanova L, Djambazov V, Gergova G, et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe 2004, 10:261-267.
67. Hourmont K, Klingler PJ, Wetscher G, Kafka R, Gadenstätter M, Bonatti H Capnocytophaga pleural empyema following laparoscopic Nissen fundoplication. A rare complication, a rare pathogen. Surg Endosc 2000, 14:866.
68. Valipour A, Koller H, Setinek U, Burghuber OC Pleural empyema associated with Gemella morbillorum: report of a case and review of the literature. Scand J Infect Dis 2005, 37:378-381.
69. Baracaldo R, Foltzer M, Patel R, Bourbeau P Empyema caused by Mycoplasma salivarium. J Clin Microbiol 2012, 50:1805-1806.
70. Hoyler SL, Antony S Eikenella corrodens: an unusual cause of severe parapneumonic infection and empyema in immunocompetent patients. J Natl Med Assoc 2001, 93:224-229.
71. Ko SC, Chen KY, Hsueh PR, Luh KT, Yang PC Fungal empyema thoracis: an emerging clinical entity. Chest 2000, 117:1672-1678.
72. Wahidi MM, Willner DA, Snyder LD, Hardison JL, Chia JY, Palmer SM Diagnosis and outcome of early pleural space infection following lung transplantation. Chest 2009, 135:484-491.
73. Wrightson JM, Rahman NM, Novak T, et al. Pneumocystis jirovecii in pleural infection: a nucleic acid amplification study. Thorax 2011, 66:450-451.
74. Ampofo K, Herbener A, Blaschke AJ, et al. Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J 2010, 29:905-909.
75. Sevin CM, Peng S, Skouras V, et al. Do viral infections cause pleural effusions?. Am J Respir Crit Care Med 2009, 179:A4459. (abstr).
76. Galmès J, Li Y, Rajoharison A, et al. Potential implication of new torque teno mini viruses in parapneumonic empyema in children. Eur Respir J 2013, 42:470-479.
77. Lewis KL, Doherty DE, Ribes J, Seabolt JP, Bensadoun ES Empyema caused by trichomonas. Chest 2003, 123:291-292.
78. Menzies SM, Rahman NM, Wrightson JM, et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011, 66:658-662.
79. Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis 2006, 42:1135-1140.
80. Strachan RE, Cornelius A, Gilbert GL, et al. A bedside assay to detect Streptococcus pneumoniae in children with empyema. Pediatr Pulmonol 2011, 46:179-183. the Australian Research Network in Empyema (ARNiE).
81. Strachan RE, Cornelius A, Gilbert GL, et al. Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children. Respirology 2012, 17:114-119.
82. Falguera M, López A, Nogués A, Porcel JM, Rubio-Caballero M Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest 2002, 122:2212-2216.
83. Wrightson JM, Rahman NM, Crook DW, Wray JA Improving pathogen identification in pleural infection-application of molecular techniques. Am J Respir Crit Care Med 2012, 185:A5244. (abstr).
84. Muñoz-Almagro C, Gala S, Selva L, Jordan I, Tarragó D, Pallares R DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema. Eur J Clin Microbiol Infect Dis 2011, 30:327-335.
85. Saglani S, Harris KA, Wallis C, Hartley JC Empyema: the use of broad range 16S rDNA PCR for pathogen detection. Arch Dis Child 2005, 90:70-73.
86. Tillett WS, Sherry S The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest 1949, 28:173-190.
87. Cameron R, Davies HR Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004, CD002312.
88. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004, 170:49-53.
89. Komissarov AA, Florova G, Azghani A, Karandashova S, Kurdowska AK, Idell S Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids. Am J Physiol Lung Cell Mol Physiol 2013, 305:L682-L692.
90. Karandashova S, Florova G, Azghani AO, et al. Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol 2013, 48:44-52.
91. Florova G, Azghani A, Karandashova S, et al. Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol 2015, 52:429-437.
92. Simpson G, Roomes D, Heron M Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000, 117:1728-1733.
93. Light RW, Nguyen T, Mulligan ME, Sasse SA The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000, 178:13-18.
94. Piccolo F, Pitman N, Bhatnagar R, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc 2014, 11:1419-1425.
95. Lansley SM, Cheah HM, Varano Della Vergiliana JF, Chakera A, Lee YG Tissue plasminogen activator potently stimulates pleural effusion via an MCP-1 Dependent Mechanism. Am J Respir Cell Mol Biol 2014, published online Dec 4. 10.1165/rcmb.2014-0017OC.
96. Hooper AJ, Wallis AJ, Clive AO, et al. Pleural Irrigation Trial (PIT): standard care versus pleural irrigation, a randomised controlled trial in patients with pleural infection. Thorax 2012, 67:A11.
97. Nasreen N, Mohammed KA, Galffy G, Ward MJ, Antony VB MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells. Am J Physiol Lung Cell Mol Physiol 2000, 278:L591-L598.
98. Solaini L, Prusciano F, Bagioni P Video-assisted thoracic surgery in the treatment of pleural empyema. Surg Endosc 2007, 21:280-284.
99. Chung JH, Lee SH, Kim KT, Jung JS, Son HS, Sun K Optimal timing of thoracoscopic drainage and decortication for empyema. Ann Thorac Surg 2014, 97:224-229.
100. Schweigert M, Solymosi N, Dubecz A, et al. Surgical management of pleural empyema in the very elderly. Ann R Coll Surg Engl 2012, 94:331-335.
101. Chambers A, Routledge T, Dunning J, Scarci M Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema?. Interact Cardiovasc Thorac Surg 2010, 11:171-177.
102. Kho P, Karunanantham J, Leung M, Lim E Debridement alone without decortication can achieve lung re-expansion in patients with empyema: an observational study. Interact Cardiovasc Thorac Surg 2011, 12:724-727.
103. Tacconi F, Pompeo E, Fabbi E, Mineo TC Awake video-assisted pleural decortication for empyema thoracis. Eur J Cardiothorac Surg 2010, 37:594-601.
104. Brutsche MH, Tassi GF, Györik S, et al. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest 2005, 128:3303-3309.
105. Ravaglia C, Gurioli C, Tomassetti S, et al. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic empyema?. Respiration 2012, 84:219-224.
106. Wait MA, Sharma S, Hohn J, Dal Nogare A A randomized trial of empyema therapy. Chest 1997, 111:1548-1551.
107. Bilgin M, Akcali Y, Oguzkaya F Benefits of early aggressive management of empyema thoracis. ANZ J Surg 2006, 76:120-122.
108. Lim TK, Chin NK Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis. Eur Respir J 1999, 13:514-518.
109. Lardinois D, Gock M, Pezzetta E, et al. Delayed referral and gram-negative organisms increase the conversion thoracotomy rate in patients undergoing video-assisted thoracoscopic surgery for empyema. Ann Thorac Surg 2005, 79:1851-1856.
110. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006, 174:221-227.
111. Marhuenda C, Barceló C, Fuentes I, et al. Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial. Pediatrics 2014, 134:e1301-e1307.
112. St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 2009, 44:106-111.
113. Kurt BA, Winterhalter KM, Connors RH, Betz BW, Winters JW Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage. Pediatrics 2006, 118:e547-e553.
114. Grijalva CG, Nuorti JP, Zhu Y, Griffin MR Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 2010, 50:805-813.
115. Grabenstein JD, Musey LK Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults. Vaccine 2014, 32:2399-2405.
116. Botianu PV, Dobrica AC, Butiurca A, Botianu AM Complex space-filling procedures for intrathoracic infections-personal experience with 76 consecutive cases. Eur J Cardiothorac Surg 2010, 37:478-481.
117. Reyes KG, Mason DP, Murthy SC, Su JW, Rice TW Open window thoracostomy: modern update of an ancient operation. Thorac Cardiovasc Surg 2010, 58:220-224.
118. Palmen M, van Breugel HM, Geskes GG, et al. Open window thoracostomy treatment of empyema is accelerated by vacuum-assisted closure. Ann Thorac Surg 2009, 88:1131-1136.
119. Davies HE, Rahman NM, Parker RJ, Davies RJ Use of indwelling pleural catheters for chronic pleural infection. Chest 2008, 133:546-549.
120. Corcoran JP, Ahmad M, Mukherjee R, Redmond KC Pleuro-pulmonary complications of rheumatoid arthritis. Respir Care 2014, 59:55-59.
121. Sasse S, Nguyen T, Teixeira LR, Light R The utility of daily therapeutic thoracentesis for the treatment of early empyema. Chest 1999, 116:1703-1708.
122. Chen KY, Liaw YS, Wang HC, Luh KT, Yang PC Sonographic septation: a useful prognostic indicator of acute thoracic empyema. J Ultrasound Med 2000, 19:837-843.
123. Teixeira LR, Sasse SA, Villarino MA, Nguyen T, Mulligan ME, Light RW Antibiotic levels in empyemic pleural fluid. Chest 2000, 117:1734-1739.
124. Saroglou M, Tryfon S, Ismailos G, et al. Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion. J Inflamm (Lond) 2010, 7:22.
125. Liapakis IE, Kottakis I, Tzatzarakis MN, et al. Penetration of newer quinolones in the empyema fluid. Eur Respir J 2004, 24:466-470.
126. Mullins MM, Walker I, Standridge RD Using povidone-iodine to treat empyema. J Wound Care 2001, 10:155-156.
127. Suissa S, Dell'Aniello S, Ernst P Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012, 67:957-963.
128. Schmidt SA, Johansen MB, Olsen M, et al. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study. BMJ Open 2014, 4:e006720.
129. Guertler C, Wirz B, Christ-Crain M, Zimmerli W, Mueller B, Schuetz P Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J 2011, 37:1439-1446.
130. Bruns AH, Oosterheert JJ, Cucciolillo MC, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect 2011, 17:763-768.
131. Restrepo MI, Faverio P, Anzueto A Long-term prognosis in community-acquired pneumonia. Curr Opin Infect Dis 2013, 26:151-158.